Krsnaa Diagnostics to meet investors and analysts in Singapore

Krsnaa Diagnostics Limited announced it will conduct one-on-one interactions with several investors and analysts in Singapore on September 29, 2025. The physical meetings, scheduled to begin at 09:30 Singapore Standard Time, will involve Dymon Asia, NNikko Asset Management, Nalanda Capital, Oxbow Capital Management, and ADD Capital (FO).

The purpose of these meetings, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is to provide an opportunity for investors and analysts to engage directly with company officials. Discussions are expected to be based on publicly available information.

Krsnaa Diagnostics confirmed that no unpublished price-sensitive information is intended to be discussed during these interactions. The company also noted that the schedule is subject to change due to potential exigencies. The intimation was signed by Sujoy Sudipta Bose, company secretary and compliance officer.